Pharmacies across the U.S. will begin receiving shipments of a generic form of the revolutionary cancer pill Gleevec this week after the drug lost its patent protection on Monday. The generic ...

Mann would be among the earliest patients to try a new medication called Gleevec. He might get a dose too low to be effective and the drug might not work at all, the doctor warned. But Mann ...

How do scientists develop new treatments for disease? With Gleevec, a remarkable cancer drug, the approach was to target the disease at the cellular and subcellular level. When people say Gleevec ...

In this episode of the “CURE® Talks Cancer” podcast Mel Mann discusses his participation in the clinical trial for Gleevec and how it changed the trajectory of his life. In 1998, Mel Mann received his ...

Average wholesale price of Gleevec per year at 400 mg per day—typical dosing ... as part of a broader strategy for promoting optimal delivery of patient care. A Timeline Leading Up to the First ...

The basic compound patent for Gleevec expires in the U.S. on July 4, 2015. As a result of the settlement, Novartis will permit Sun Pharma`s subsidiary to market a generic version of Gleevec in the ...

It's a dark day at Novartis ($NVS). Sun Pharma rolled out its copycat version of Novartis' blockbuster cancer drug Gleevec, setting the Swiss drugmaker up for a big ...

People who are using Gleevec and have high blood pressure, diabetes or a history of heart disease should talk to their doctor about the risks of heart failure, the company said. Anyone on the drug ...